glp 1 for 12 year olds CHOP doctors identify barriers to GLP-1 drugs obese kids Prescribing GLP-1 to an overweight

Description

Breakfast, lunch, and dinner recipes planned for you

BCBS Michigan cites concerns about safety, effectiveness, and cost for this decision

Amylyx continues to expect topline data in Q3 2026, and if approved, a commercial launch in 2027

The global Obesity Medicines market reached $66 billion in list price sales value in 2025, according to IQVIAs ForecastLink, and is forecast to rise to $92 billion in 2026, before reaching between $105 billion and $200 billion by 2027 and beyond

Multivariate analysis showed no difference between placebo and liraglutide arms in HbA1c at 6 months (HbA1c:0.2mmol/mol, 11.3, 11.6, p=0.98) however, at 12 months HbA1c was significantly higher in the liraglutide arm (HbA1c:10.9mmol/mol, 1.1, 20.6, p=0.032)